News
![Boehringer files for new rare disease use for nintedanib in EU, US](/sites/default/files/styles/x_large/public/default_images/empty.jpg?itok=C-Mgnvzj)
Boehringer files for new rare disease use for nintedanib in ...
Boehringer Ingelheim has filed for a new use for its lung drug nintedanib in the US and Europe, bidding to add the rare disease systemic sclerosis to the existing indication for idiopathic